Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9612 posts found.

chris-thatcher-headshot_750xx1602-2136-155-0_1

Chris Thatcher to step down as President and CEO of Neuronetics

March 9, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Neuronetics, Inc and Chris Thatcher, the President and CEO, have mutually agreed that he will step down from his positions …
Appointment
what-is-pharmacovigilance-328154

The need for evolution in pharmacovigilance

March 9, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing feature, pharma, pharmacovigilance

Pharmacovigilance is a critical function in ensuring public health, but is our current system built to tackle the challenges of …
Feature
4420456374_64a3d7e6aa_75

Top Ten most popular articles on Pharmafile.com this week

March 6, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Chinese Coronavirus, Wuhan Coronavirus, china coronavirus, coronavirus, wuhan coronavirus.

The coronavirus continues to threaten the global drug supply line, with disruption to the US drug production pipeline from the …
News
shutterstock

Scorpion venom added to CAR-T therapy increases efficacy in brain cancer, research shows

March 6, 2020 Medical Communications, Research and Development CAR-T, Cancer, brain cancer, glioblastoma, pharma

Chimeric antigen receptor T cell (CAR-T) therapy has gained much traction and attention in the past years for its innovative …
News
az_logo

Phase 3 failure for AstraZeneca’s Imfinzi combo in unresectable metastatic bladder cancer

March 6, 2020 Medical Communications, Research and Development AstraZeneca, Cancer, Imfinzi, bladder cancer, pharma, trial failure

New Phase 3 has been released by AstraZeneca, showing that the PD-L1 inhibitor Imfinzi (durvalumab), when combined with tremelimumab, failed …
News
shutterstock_138095450

New study calculates median drug development costs at circa $1 billion

March 5, 2020 Manufacturing and Production, Research and Development, Sales and Marketing drug development, drug prices, pharma

New research has pinned a concrete figure on the perennial industry question: how much does it cost to bring a …
News
takeda_logo_506_small

Positive CHMP approval for Takeda’s Alunbrig in ALK+ advanced non-small lung cancer

March 4, 2020 Research and Development CHMP, EMA, Takeda, lung cancer, pharma

Takeda’s Alunbrig (brigatinib) has been recommended for approval by the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human …
News
chart-trading-courses-forex-preview

Big Pharma more profitable than most public firms

March 4, 2020 Research and Development Big Pharma, US Pharma, drug prices, drug regulations, regulations

Large pharmaceutical companies make a much larger profit than most other public companies, according to a new study. The research …
News
diet-pills-medication-pharmacy-sick

India reducing API exports due to coronavirus threatening global supply chain

March 4, 2020 Research and Development APIs, Active Pharmaceuticals Ingredients, Big Pharma, Chinese Coronavirus, Wuhan Coronavirus, coronavirus

India is set to reduce exports of active pharmaceutical ingredients (APIs) until further notice, due to fears of internal drug …
News
nice_new_london_office_internal_3_web

NICE recommends avatrombopag to treat thrombocytopenia in chronic liver disease

March 4, 2020 Research and Development Avatrombopag, NHS, NICE, UK, chronic liver disease

UK drug watchdog NICE has announced its final draft guidance recommending avatrombopag for routine use on the NHS in England …
News
48317770967_48ec28d656_b

Trump meets pharmaceutical executives to discuss COVID-19 vaccine

March 4, 2020 Research and Development COVID-19, Chinese Coronavirus, Trump, Wuhan Coronavirus, coronavirus

President Trump has met with several representatives of the top pharmaceutical companies to discuss progress being made on a coronavirus …
News
michael-jewell

Funding overview for the pharmaceutical industry and outlook for 2020

March 2, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2020, M&A, MA, feature, mergers & acquisitions, opinion, pharma

This article was originally published in the January/February 2020 issue of Pharmafocus.With the advent of a New Year, Michael Jewell, …
Feature
top_10_image_2_1

Top Ten most popular articles on Pharmafile.com this week

February 28, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Chinese Coronavirus, Johnson and Johnson, Wuhan Coronavirus, coronavirus

The coronavirus continues to spread across the globe as the US launch their first trials for Gilead’s ebola drug remdesivir …
News
pharmafocus_march_2020_cover

The March 2020 issue of Pharmafocus is available to read free online now!

February 27, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing England, Pharmafocus, UK, mumps, pharma, pharmacovigilance, type 2 diabetes

The latest monthly edition of Pharmafocus, the March issue, is available to read for free online now! The coronavirus continues …
News

Female participation up in 2019 US clinical trials, but minority representation down

February 27, 2020 Medical Communications, Research and Development FDA, clinical trials, pharma

The FDA’s Drugs Trials Snapshots 2019 report has been released, clarifying the demographic distribution of participants who were included in …
News
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026